Neogenix awarded Emerging Company of the Year by TCM

Download PDF Copy

Reviewed

Neogenix Oncology, Inc.May 15 2010

Neogenix Oncology, Inc. (Neogenix), announced today that they were awarded "Emerging Company of the Year" by The Tech Council of Maryland (TCM), the state's largest technology trade association at its 22nd Annual Tech Awards including more than 800 technology and business leaders from around the region.

“We are honored and proud to accept the 'Emerging Company of the Year' award and I want to congratulate everyone at Neogenix who made this possible. We are looking forward to growing successfully in the future”

"We are honored and proud to accept the 'Emerging Company of the Year' award and I want to congratulate everyone at Neogenix who made this possible. We are looking forward to growing successfully in the future," said Dr. Philip Arlen, CEO of Neogenix Oncology.

Source:

Neogenix Oncology, Inc.

Posted in:

Comments (0)

Download PDF Copy

Suggested Reading

New tool helps identify risky medications for older cancer patients

Inside the lab of the future: Automation, NMR, and the power of integration

Johns Hopkins team develops urine-based test for prostate cancer detection

Scaling organ‑chip technology for human‑relevant drug discovery

Primary care could help meet growing needs of cancer survivors

NYU Langone strengthens world-leading GI cancer program with renowned leaders

Urine test identifies three biomarkers for accurate prostate cancer detection

Breakthrough discovery reveals treatable form of familial mesothelioma

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.